The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global High Content Screening Products Market Research Report 2025
Synopsis
High-content screening (HCS), also known as high-content analysis (HCA) or cellomics, is a method that is used in biological research and drug discovery to identify substances such as small molecules, peptides, or RNAi that alter the phenotype of a cell in a desired manner.
The global High Content Screening Products market was valued at US$ 848.8 million in 2023 and is anticipated to reach US$ 1193.2 million by 2030, witnessing a CAGR of 4.5% during the forecast period 2024-2030.
North American market for High Content Screening Products is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for High Content Screening Products is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for High Content Screening Products in Pharmaceutical is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of High Content Screening Products include Becton Dickinson, Thermo Fisher Scientific, GE Healthcare, Olympus LifeScience, PerkinElmer, Merck Millipore, Danaher, Yokogawa Electric and Sysmex, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for High Content Screening Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding High Content Screening Products.
Report Scope
The High Content Screening Products market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global High Content Screening Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the High Content Screening Products companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Becton Dickinson
Thermo Fisher Scientific
GE Healthcare
Olympus LifeScience
PerkinElmer
Merck Millipore
Danaher
Yokogawa Electric
Sysmex
Thorlabs
Valeo
Montaplast
Segment by Type
Consumables
Instruments
Software
Service
Accessories
Segment by Application
Pharmaceutical
Biotechnology Companies
Academic and Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of High Content Screening Products companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
High-content screening (HCS), also known as high-content analysis (HCA) or cellomics, is a method that is used in biological research and drug discovery to identify substances such as small molecules, peptides, or RNAi that alter the phenotype of a cell in a desired manner.
The global High Content Screening Products market was valued at US$ 848.8 million in 2023 and is anticipated to reach US$ 1193.2 million by 2030, witnessing a CAGR of 4.5% during the forecast period 2024-2030.
North American market for High Content Screening Products is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for High Content Screening Products is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for High Content Screening Products in Pharmaceutical is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of High Content Screening Products include Becton Dickinson, Thermo Fisher Scientific, GE Healthcare, Olympus LifeScience, PerkinElmer, Merck Millipore, Danaher, Yokogawa Electric and Sysmex, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for High Content Screening Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding High Content Screening Products.
Report Scope
The High Content Screening Products market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global High Content Screening Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the High Content Screening Products companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Becton Dickinson
Thermo Fisher Scientific
GE Healthcare
Olympus LifeScience
PerkinElmer
Merck Millipore
Danaher
Yokogawa Electric
Sysmex
Thorlabs
Valeo
Montaplast
Segment by Type
Consumables
Instruments
Software
Service
Accessories
Segment by Application
Pharmaceutical
Biotechnology Companies
Academic and Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of High Content Screening Products companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global High Content Screening Products Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Consumables
1.2.3 Instruments
1.2.4 Software
1.2.5 Service
1.2.6 Accessories
1.3 Market by Application
1.3.1 Global High Content Screening Products Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical
1.3.3 Biotechnology Companies
1.3.4 Academic and Research Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global High Content Screening Products Market Perspective (2019-2030)
2.2 High Content Screening Products Growth Trends by Region
2.2.1 Global High Content Screening Products Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 High Content Screening Products Historic Market Size by Region (2019-2024)
2.2.3 High Content Screening Products Forecasted Market Size by Region (2025-2030)
2.3 High Content Screening Products Market Dynamics
2.3.1 High Content Screening Products Industry Trends
2.3.2 High Content Screening Products Market Drivers
2.3.3 High Content Screening Products Market Challenges
2.3.4 High Content Screening Products Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top High Content Screening Products Players by Revenue
3.1.1 Global Top High Content Screening Products Players by Revenue (2019-2024)
3.1.2 Global High Content Screening Products Revenue Market Share by Players (2019-2024)
3.2 Global High Content Screening Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by High Content Screening Products Revenue
3.4 Global High Content Screening Products Market Concentration Ratio
3.4.1 Global High Content Screening Products Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by High Content Screening Products Revenue in 2023
3.5 High Content Screening Products Key Players Head office and Area Served
3.6 Key Players High Content Screening Products Product Solution and Service
3.7 Date of Enter into High Content Screening Products Market
3.8 Mergers & Acquisitions, Expansion Plans
4 High Content Screening Products Breakdown Data by Type
4.1 Global High Content Screening Products Historic Market Size by Type (2019-2024)
4.2 Global High Content Screening Products Forecasted Market Size by Type (2025-2030)
5 High Content Screening Products Breakdown Data by Application
5.1 Global High Content Screening Products Historic Market Size by Application (2019-2024)
5.2 Global High Content Screening Products Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America High Content Screening Products Market Size (2019-2030)
6.2 North America High Content Screening Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America High Content Screening Products Market Size by Country (2019-2024)
6.4 North America High Content Screening Products Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe High Content Screening Products Market Size (2019-2030)
7.2 Europe High Content Screening Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe High Content Screening Products Market Size by Country (2019-2024)
7.4 Europe High Content Screening Products Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific High Content Screening Products Market Size (2019-2030)
8.2 Asia-Pacific High Content Screening Products Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific High Content Screening Products Market Size by Region (2019-2024)
8.4 Asia-Pacific High Content Screening Products Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America High Content Screening Products Market Size (2019-2030)
9.2 Latin America High Content Screening Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America High Content Screening Products Market Size by Country (2019-2024)
9.4 Latin America High Content Screening Products Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa High Content Screening Products Market Size (2019-2030)
10.2 Middle East & Africa High Content Screening Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa High Content Screening Products Market Size by Country (2019-2024)
10.4 Middle East & Africa High Content Screening Products Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Becton Dickinson
11.1.1 Becton Dickinson Company Detail
11.1.2 Becton Dickinson Business Overview
11.1.3 Becton Dickinson High Content Screening Products Introduction
11.1.4 Becton Dickinson Revenue in High Content Screening Products Business (2019-2024)
11.1.5 Becton Dickinson Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific High Content Screening Products Introduction
11.2.4 Thermo Fisher Scientific Revenue in High Content Screening Products Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 GE Healthcare
11.3.1 GE Healthcare Company Detail
11.3.2 GE Healthcare Business Overview
11.3.3 GE Healthcare High Content Screening Products Introduction
11.3.4 GE Healthcare Revenue in High Content Screening Products Business (2019-2024)
11.3.5 GE Healthcare Recent Development
11.4 Olympus LifeScience
11.4.1 Olympus LifeScience Company Detail
11.4.2 Olympus LifeScience Business Overview
11.4.3 Olympus LifeScience High Content Screening Products Introduction
11.4.4 Olympus LifeScience Revenue in High Content Screening Products Business (2019-2024)
11.4.5 Olympus LifeScience Recent Development
11.5 PerkinElmer
11.5.1 PerkinElmer Company Detail
11.5.2 PerkinElmer Business Overview
11.5.3 PerkinElmer High Content Screening Products Introduction
11.5.4 PerkinElmer Revenue in High Content Screening Products Business (2019-2024)
11.5.5 PerkinElmer Recent Development
11.6 Merck Millipore
11.6.1 Merck Millipore Company Detail
11.6.2 Merck Millipore Business Overview
11.6.3 Merck Millipore High Content Screening Products Introduction
11.6.4 Merck Millipore Revenue in High Content Screening Products Business (2019-2024)
11.6.5 Merck Millipore Recent Development
11.7 Danaher
11.7.1 Danaher Company Detail
11.7.2 Danaher Business Overview
11.7.3 Danaher High Content Screening Products Introduction
11.7.4 Danaher Revenue in High Content Screening Products Business (2019-2024)
11.7.5 Danaher Recent Development
11.8 Yokogawa Electric
11.8.1 Yokogawa Electric Company Detail
11.8.2 Yokogawa Electric Business Overview
11.8.3 Yokogawa Electric High Content Screening Products Introduction
11.8.4 Yokogawa Electric Revenue in High Content Screening Products Business (2019-2024)
11.8.5 Yokogawa Electric Recent Development
11.9 Sysmex
11.9.1 Sysmex Company Detail
11.9.2 Sysmex Business Overview
11.9.3 Sysmex High Content Screening Products Introduction
11.9.4 Sysmex Revenue in High Content Screening Products Business (2019-2024)
11.9.5 Sysmex Recent Development
11.10 Thorlabs
11.10.1 Thorlabs Company Detail
11.10.2 Thorlabs Business Overview
11.10.3 Thorlabs High Content Screening Products Introduction
11.10.4 Thorlabs Revenue in High Content Screening Products Business (2019-2024)
11.10.5 Thorlabs Recent Development
11.11 Valeo
11.11.1 Valeo Company Detail
11.11.2 Valeo Business Overview
11.11.3 Valeo High Content Screening Products Introduction
11.11.4 Valeo Revenue in High Content Screening Products Business (2019-2024)
11.11.5 Valeo Recent Development
11.12 Montaplast
11.12.1 Montaplast Company Detail
11.12.2 Montaplast Business Overview
11.12.3 Montaplast High Content Screening Products Introduction
11.12.4 Montaplast Revenue in High Content Screening Products Business (2019-2024)
11.12.5 Montaplast Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
